Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

E. F. Morand. 1998. Involvement of
macrophage migration inhibitory factor
in the evolution of rat adjuvant arthritis.
Arthritis Rheum. 41: 910.
184 Calandra, T., B. Echtenacher,
D. L. Roy, J. Pugin, C. N. Metz,
L. Hultner, D. Heumann, D. Mannel,
R. Bucala and M. P. Glauser. 2000.
Protection from septic shock by neutralization
of macrophage migration inhibitory
factor. Nat. Med. 6: 164.
185 Lan, H. Y., M. Bacher, N. Yang,W. Mu,
D. J. Nikolic-Paterson, C. Metz,
A. Meinhardt, R. Bucala and
R. C. Atkins. 1997. The pathogenic
role of macrophage migration inhibitory
factor in Immunologically induced
kidney disease in the rat. J. Exp. Med.
185: 1455.
186 Bacher, M., C. N. Metz, T. Calandra,
K. Mayer, J. Chesney, M. Lohoff,
D. Gemsa, T. Donnelly and R. Bucala.
1996. An essential regulatory role for
macrophage migration inhibitory factor
in T-cell activation. Proc. Natl Acad. Sci.
USA 93: 7849.
187 Kitaichi, N., K. Ogasawara, K. Iwabuchi,
J. Nishihira, K. Namba, K. Onoe,
J. Konishi, S. Kotake and H. Matsuda.
2000. Different influence of
macrophage migration inhibitory factor
(MIF) in signal transduction pathway of
various T cell subsets. Immunobiology
201: 356.
188 Meyer-Siegler, K., R. A. Fattor and
P. B. Hudson. 1998. Expression of
macrophage migration inhibitory factor
in the human prostate. Diagn. Mol.
Pathol. 7: 44.
189 Meyer-Siegler, K. and P. B. Hudson.
1996. Enhanced expression of macrophage
migration inhibitory factor in
prostatic adenocarcinoma metastases.
Urology 48: 448.
190 del Vecchio, M. T., S. A. Tripodi,
F. Arcuri, L. Pergola, L. Hako,
R. Vatti and M. Cintorino. 2000.
Macrophage migration inhibitory factor
in prostatic adenocarcinoma: correlation
with tumor grading and combination
endocrine treatment-related
changes. Prostate 45: 51.
191 Kamimura, A., M. Kamachi, J. Nishihira,
S. Ogura, H. Isobe, H. Dosaka-
References
Akita, A. Ogata, M. Shindoh, T. Ohbuchi
and Y. Kawakami. 2000. Intracellular
distribution of macrophage migration
inhibitory factor predicts the prognosis
of patients with adenocarcinoma
of the lung. Cancer 89: 334.
192 Markert, J. M., C. M. Fuller,
G. Y. Gillespie, J. K. Bubien,
L. A. McLean, R. L. Hong, K. Lee,
S. R. Gullans, T. B. Mapstone and
D. J. Benos. 2001. Differential gene expression
profiling in human brain tumors.
Physiol. Genomics 5: 21.
193 Mitchell, R. A., C. N. Metz, T. Peng
and R. Bucala. 1999. Sustained mitogen-activated
protein kinase (MAPK)
and cytoplasmic phospholipase A2 activation
by macrophage migration inhibitory
factor (MIF). Regulatory role in cell
proliferation and glucocorticoid action.
J. Biol. Chem. 274: 18100.
194 Takahashi, N., J. Nishihira,Y. Sato,
M. Kondo, H. Ogawa, T. Ohshima,
Y. Une and S. Todo. 1998. Involvement
of macrophage migration inhibitory
factor (MIF) in the mechanism of tumor
cell growth. Mol. Med. 4: 707.
195 Takahashi, A., K. Iwabuchi, M. Suzuki,
K. Ogasawara, J. Nishihira and
K. Onoe. 1999. Antisense macrophage
migration inhibitory factor (MIF) prevents
anti- IgM mediated growth arrest
and apoptosis of a murine B cell line by
regulating cell cycle progression. Microbiol.
Immunol. 43: 61.
196 Takahashi, N., J. Nishihira,Y. Sato,
M. Kondo, H. Ogawa, T. Ohshima,
Y. Une and S. Todo. 1998. Involvement
of macrophage migration inhibitory
factor (MIF) in the mechanism of tumor
cell growth. Mol. Med. 4: 707.
197 Hudson, J. D., M. A. Shoaibi,
R. Maestro, A. Carnero, G. J. Hannon
and D. H. Beach. 1999. A proinflammatory
cytokine inhibits p53 tumor
suppressor activity. J. Exp. Med.
190: 1375.
198 Chesney, J., C. Metz, M. Bacher, T.
Peng, A. Meinhardt and R. Bucala.
1999. An essential role for macrophage
migration inhibitory factor (MIF) in angiogenesis
and the growth of a murine
lymphoma. Mol. Med. 5: 181.
147